Biomarin Pharmaceutical Inc. (bmrn) a Stock That Could 10x by 2030 on Pipeline Development
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the stocks that could 10x by 2030. Wainwright reiterated a Neutral rating on BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) with a $50 price target. The cautious outlook comes on the heels of BioMarin Pharmaceutical deliveri